Growth Metrics

Tandem Diabetes Care (TNDM) EBT Margin Growth (3y) (2016 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -305.00
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -9.00
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -222.00
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 923.00
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -480.00
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 2,114.00
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 1,391.00
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -176.00
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 329.00
10 Tandem Diabetes Care 1.31 Bn 739.55 Mn 136.79 Mn 6,492.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 6,492.00
Dec 31, 2025 894.00
Sep 30, 2025 1,306.00
Jun 30, 2025 -1,752.00
Mar 31, 2025 -4,276.00
Dec 31, 2024 -528.00
Sep 30, 2024 -1,252.00
Jun 30, 2024 -1,577.00
Mar 31, 2024 -1,696.00
Dec 31, 2023 -2,607.00
Sep 30, 2023 -896.00
Jun 30, 2023 905.00
Mar 31, 2023 -5,788.00
Dec 31, 2022 -983.00
Sep 30, 2022 -2,016.00
Jun 30, 2022 -485.00
Mar 31, 2022 2,552.00
Dec 31, 2021 38.00
Sep 30, 2021 7,728.00
Jun 30, 2021 4,250.00
Mar 31, 2021 5,278.00
Dec 31, 2020 3,377.00
Sep 30, 2020 4,096.00
Jun 30, 2020 6,195.00
Mar 31, 2020 9,646.00
Dec 31, 2019 4,855.00
Sep 30, 2019 22,787.00
Jun 30, 2019 7,210.00
Mar 31, 2019 6,049.00
Dec 31, 2018 4,313.00
Sep 30, 2018 4,443.00
Jun 30, 2018 7,835.00
Mar 31, 2018 10,859.00
Dec 31, 2017 7,402.00
Sep 30, 2017 9,190.00
Jun 30, 2017 8,968.00
Mar 31, 2017 14,657.00
Dec 31, 2016 11,460.00
Sep 30, 2016 -7,491.00
Jun 30, 2016 17,368.00
Mar 31, 2016 3,598.00